Sponsored Webinar: Biomarker-Enhanced Clinical Assessment of Sepsis and Acute Kidney Injury
Sponsored by bioMérieux
This session overviews clinical assessment of acute kidney injury using biomarkers.
This course was originally recorded on 2/23/2021
Nurses, physicians, pharmacists, emergency responders, healthcare management teams, and other healthcare staff may benefit.
At the end of the presentation, the attendee should be able to:
- Understand the role of renal biomarkers in assessment of AKI with clinical judgement.
- Understand the role of procalcitonin in tracking, assessing and delineating sepsis.
- Understand the interplay in intensive care of multiple biomarkers in assessing care.
Sepsis Alliance gratefully acknowledges the support provided for this sponsor innovation webinar by bioMérieux.
Louis Guzzi, MD, FCCM
Director, Critical Care Medicine, Florida Hospital Orlando
Dr. Guzzi is quadruple board-certified in critical care medicine, anesthesiology, internal medicine and neocritical care. He cares for patients at Florida Hospital Orlando and has more than 20 years of experience to his name. Dr. Guzzi is a graduate of the Georgetown University School of Medicine in Washington, D.C. and carried out his residency training at Dwight D. Eisenhower Army Medical Center and Walter Reed Army Medical Center, remaining at Walter Reed for his advanced fellowship training in critical care medicine. He actively practices both anesthesiology and critical care medicine and lectures both nationally and internationally on both topics.